{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:40:33Z","timestamp":1790707233150,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.tcm.2010.02.008","type":"journal-article","created":{"date-parts":[[2010,5,5]],"date-time":"2010-05-05T12:53:15Z","timestamp":1273063995000},"page":"262-267","source":"Crossref","is-referenced-by-count":9,"title":["Ras-Association Domain Family Member 1A (RASSF1A)\u2014Where the Heart and Cancer Meet"],"prefix":"10.1016","volume":"19","author":[{"given":"Delvac","family":"Oceandy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Cartwright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig","family":"Neyses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2010.02.008_bib1","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1158\/0008-5472.CAN-04-4088","article-title":"Role of the Ras-association domain family 1 tumor suppressor gene in human cancers","volume":"65","author":"Agathanggelou","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.tcm.2010.02.008_bib2","doi-asserted-by":"crossref","first-page":"31318","DOI":"10.1074\/jbc.M307557200","article-title":"Novel functional interaction between the plasma membrane Ca2+ pump 4b and the proapoptotic tumor suppressor Ras-associated factor 1 (RASSF1)","volume":"279","author":"Armesilla","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tcm.2010.02.008_bib3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nm0306-283","article-title":"Stops along the RAS pathway in human genetic disease","volume":"12","author":"Bentires-Alj","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.tcm.2010.02.008_bib4","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/jnci\/93.9.691","article-title":"Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression","volume":"93","author":"Burbee","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.tcm.2010.02.008_bib5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0092-8674(03)00355-6","article-title":"Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase","volume":"113","author":"Cheung","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.tcm.2010.02.008_bib6","doi-asserted-by":"crossref","first-page":"C323","DOI":"10.1152\/ajpcell.1987.252.3.C323","article-title":"Faster ribosome synthesis induced by elevated aortic pressure in rat heart","volume":"252","author":"Chua","year":"1987","journal-title":"Am J Physiol"},{"key":"10.1016\/j.tcm.2010.02.008_bib7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/77083","article-title":"Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3","volume":"25","author":"Dammann","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.tcm.2010.02.008_bib8","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1242\/jcs.010389","article-title":"The RASSF1A tumor suppressor","volume":"120","author":"Donninger","year":"2007","journal-title":"J Cell Sci"},{"key":"10.1016\/j.tcm.2010.02.008_bib9","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1161\/01.RES.0000077012.11088.BC","article-title":"Phenotyping hypertrophy: eschew obfuscation","volume":"92","author":"Dorn","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.tcm.2010.02.008_bib10","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1073\/pnas.131216298","article-title":"The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis","volume":"98","author":"Dreijerink","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tcm.2010.02.008_bib11","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1128\/MCB.02011-07","article-title":"Dynamics of RASSF1A\/MOAP-1 association with death receptors","volume":"28","author":"Foley","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.tcm.2010.02.008_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ng1059","article-title":"Nf1 has an essential role in endothelial cells","volume":"33","author":"Gitler","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.tcm.2010.02.008_bib13","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0025-6196(12)60746-0","article-title":"Oncogenes","volume":"60","author":"Gordon","year":"1985","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.tcm.2010.02.008_bib14","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.cub.2009.10.040","article-title":"ATM regulates a RASSF1A-dependent DNA damage response","volume":"19","author":"Hamilton","year":"2009","journal-title":"Curr Biol"},{"key":"10.1016\/j.tcm.2010.02.008_bib15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","article-title":"Regulation of cardiac hypertrophy by intracellular signalling pathways","volume":"8","author":"Heineke","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.tcm.2010.02.008_bib16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1073\/pnas.85.2.339","article-title":"Proto-oncogene induction and reprogramming of cardiac gene expression produced by pressure overload","volume":"85","author":"Izumo","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tcm.2010.02.008_bib17","doi-asserted-by":"crossref","first-page":"22607","DOI":"10.1016\/S0021-9258(17)31689-7","article-title":"Tumor suppressor gene expression during normal and pathologic myocardial growth","volume":"269","author":"Kim","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tcm.2010.02.008_bib18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0002-9343(03)00158-X","article-title":"A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension","volume":"115","author":"Klingbeil","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.tcm.2010.02.008_bib19","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/01.RES.62.6.1075","article-title":"Expression of cellular oncogenes in the myocardium during the developmental stage and pressure-overloaded hypertrophy of the rat heart","volume":"62","author":"Komuro","year":"1988","journal-title":"Circ Res"},{"key":"10.1016\/j.tcm.2010.02.008_bib20","first-page":"3498","article-title":"The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells","volume":"62","author":"Kuzmin","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.tcm.2010.02.008_bib21","first-page":"6116","article-title":"The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium","volume":"60","author":"Lerman","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.tcm.2010.02.008_bib22","doi-asserted-by":"crossref","first-page":"8125","DOI":"10.1038\/sj.onc.1206984","article-title":"Control of microtubule stability by the RASSF1A tumor suppressor","volume":"22","author":"Liu","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.tcm.2010.02.008_bib23","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/01.HYP.15.6.652","article-title":"Cell calcium, oncogenes, and hypertrophy","volume":"15","author":"Marban","year":"1990","journal-title":"Hypertension"},{"key":"10.1016\/j.tcm.2010.02.008_bib24","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1161\/CIRCRESAHA.108.180042","article-title":"Lats2 is a negative regulator of myocyte size in the heart","volume":"103","author":"Matsui","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.tcm.2010.02.008_bib25","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0006-291X(87)90977-6","article-title":"A hemodynamic load in vivo induces cardiac expression of the cellular oncogene, c-myc","volume":"147","author":"Mulvagh","year":"1987","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.tcm.2010.02.008_bib26","first-page":"H325","article-title":"Efficiency and capacity of protein synthesis are increased in pressure overload cardiac hypertrophy","volume":"255","author":"Nagai","year":"1988","journal-title":"Am J Physiol"},{"key":"10.1016\/j.tcm.2010.02.008_bib27","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0960-9822(95)00191-6","article-title":"Protein kinase C. Seeing two domains","volume":"5","author":"Newton","year":"1995","journal-title":"Curr Biol"},{"key":"10.1016\/j.tcm.2010.02.008_bib28","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/00004872-199309000-00006","article-title":"Induction of immediate-early genes by angiotensin II and endothelin-1 in adult rat cardiomyocytes","volume":"11","author":"Neyses","year":"1993","journal-title":"J Hypertens"},{"key":"10.1016\/j.tcm.2010.02.008_bib29","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/CIRCULATIONAHA.106.643791","article-title":"Neuronal nitric oxide synthase signaling in the heart is regulated by the sarcolemmal calcium pump 4b","volume":"115","author":"Oceandy","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2010.02.008_bib30","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/CIRCULATIONAHA.109.868554","article-title":"Tumor suppressor Ras-association domain family 1 isoform A is a novel regulator of cardiac hypertrophy","volume":"120","author":"Oceandy","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2010.02.008_bib31","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1161\/01.RES.0000265846.23485.7a","article-title":"Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction","volume":"100","author":"Odashima","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.tcm.2010.02.008_bib32","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1158\/0008-5472.CAN-05-2951","article-title":"Role of the tumor suppressor RASSF1A in Mst1-mediated apoptosis","volume":"66","author":"Oh","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.tcm.2010.02.008_bib33","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/sj.onc.1205192","article-title":"The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1","volume":"21","author":"Ortiz-Vega","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.tcm.2010.02.008_bib34","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/ng2073","article-title":"Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy","volume":"39","author":"Pandit","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.tcm.2010.02.008_bib35","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1042\/BJ20040025","article-title":"Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras","volume":"381","author":"Praskova","year":"2004","journal-title":"Biochem J"},{"key":"10.1016\/j.tcm.2010.02.008_bib36","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cardiores.2004.02.003","article-title":"Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy","volume":"63","author":"Proud","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.tcm.2010.02.008_bib37","doi-asserted-by":"crossref","first-page":"29247","DOI":"10.1074\/jbc.M401699200","article-title":"The scaffold protein CNK1 interacts with the tumor suppressor RASSF1A and augments RASSF1A-induced cell death","volume":"279","author":"Rabizadeh","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tcm.2010.02.008_bib38","first-page":"114","article-title":"The RASSF proteins in cancer; from epigenetic silencing to functional characterization","volume":"1796","author":"Richter","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.tcm.2010.02.008_bib39","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1128\/MCB.24.11.4943-4954.2004","article-title":"Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate","volume":"24","author":"Rodriguez-Viciana","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.tcm.2010.02.008_bib40","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1126\/science.1124642","article-title":"Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome","volume":"311","author":"Rodriguez-Viciana","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.tcm.2010.02.008_bib41","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nature05602","article-title":"p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload","volume":"446","author":"Sano","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.tcm.2010.02.008_bib42","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrm2221","article-title":"Filling out the Hippo pathway","volume":"8","author":"Saucedo","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.tcm.2010.02.008_bib43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrc1011","article-title":"ATM and related protein kinases: safeguarding genome integrity","volume":"3","author":"Shiloh","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.tcm.2010.02.008_bib44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ncb1091","article-title":"The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex","volume":"6","author":"Song","year":"2004","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.tcm.2010.02.008_bib45","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1161\/01.RES.0000106132.04301.F5","article-title":"Ras, Akt, and mechanotransduction in the cardiac myocyte","volume":"93","author":"Sugden","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.tcm.2010.02.008_bib46","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0092-8674(00)81766-3","article-title":"CNK, a RAF-binding multidomain protein required for RAS signaling","volume":"95","author":"Therrien","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.tcm.2010.02.008_bib47","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1158\/0008-5472.92.65.1","article-title":"Tumor susceptibility of Rassf1a knockout mice","volume":"65","author":"Tommasi","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.tcm.2010.02.008_bib48","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1126\/science.8097594","article-title":"Cytoskeletal role in the contractile dysfunction of hypertrophied myocardium","volume":"260","author":"Tsutsui","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.tcm.2010.02.008_bib49","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1038\/onc.2008.94","article-title":"Loss of Rassf1a cooperates with Apc(Min) to accelerate intestinal tumourigenesis","volume":"27","author":"Van Der Weyden","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.tcm.2010.02.008_bib50","doi-asserted-by":"crossref","first-page":"8356","DOI":"10.1128\/MCB.25.18.8356-8367.2005","article-title":"The RASSF1A isoform of RASSF1 promotes microtubule stability and suppresses tumorigenesis","volume":"25","author":"Van Der Weyden","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.tcm.2010.02.008_bib51","doi-asserted-by":"crossref","first-page":"35669","DOI":"10.1074\/jbc.C000463200","article-title":"Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis","volume":"275","author":"Vos","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tcm.2010.02.008_bib52","first-page":"976","article-title":"Plasma membrane Ca2+-ATPase isoform 4 antagonizes cardiac hypertrophy in association with calcineurin inhibition in rodents","volume":"119","author":"Wu","year":"2009","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.tcm.2010.02.008_bib53","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCRESAHA.109.201509","article-title":"Cardiomyocyte-specific loss of neurofibromin promotes cardiac hypertrophy and dysfunction","volume":"105","author":"Xu","year":"2009","journal-title":"Circ Res"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173810000265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173810000265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T01:36:04Z","timestamp":1685583364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173810000265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S1050173810000265"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2010.02.008","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}